These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 33200285
1. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital. Sinha AM, Bense J, Hohenforst-Schmidt W. J Interv Card Electrophysiol; 2021 Nov; 62(2):401-407. PubMed ID: 33200285 [Abstract] [Full Text] [Related]
2. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting. Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M. BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442 [Abstract] [Full Text] [Related]
3. Comparison of the Outcome of Patients Protected by the Wearable Cardioverter Defibrillator (WCD) for <90 Wear Days versus ≥90 Wear Days. Dreher TC, El-Battrawy I, RÖger S, Rosenkaimer SL, Gerhards S, Kuschyk J, Borggrefe M, Akin I. In Vivo; 2020 Mar 15; 34(6):3601-3610. PubMed ID: 33144474 [Abstract] [Full Text] [Related]
4. A wearable cardioverter defibrillator with a low false alarm rate. Poole JE, Gleva MJ, Birgersdotter-Green U, Branch KRH, Doshi RN, Salam T, Crawford TC, Willcox ME, Sridhar AM, Mikdadi G, Beinart SC, Cha YM, Russo AM, Rowbotham RK, Sullivan J, Gustavson LM, Kivilaid K. J Cardiovasc Electrophysiol; 2022 May 15; 33(5):831-842. PubMed ID: 35174572 [Abstract] [Full Text] [Related]
5. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death. Elbayomi M, Weyand M, Seitz T, Harig F. Ann Noninvasive Electrocardiol; 2023 Mar 15; 28(2):e13048. PubMed ID: 36723848 [Abstract] [Full Text] [Related]
6. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study. Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C. J Am Heart Assoc; 2017 Jan 17; 6(1):. PubMed ID: 28096098 [Abstract] [Full Text] [Related]
14. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator. Daimee UA, Vermilye K, Moss AJ, Goldenberg I, Klein HU, McNitt S, Zareba W, Kutyifa V. Heart Rhythm; 2018 Sep 17; 15(9):1379-1386. PubMed ID: 29678779 [Abstract] [Full Text] [Related]